# ACTION - Anticoagulation Treatment Influence on Post-operative Patients

> **NCT00187304** · PHASE4 · WITHDRAWN · sponsor: **Abbott Medical Devices**

## Conditions studied

- Heart Valve Disease

## Interventions

- **DEVICE:** Aortic valve replacement

## Key facts

- **NCT ID:** NCT00187304
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study replaced by an observational study
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187304, "ACTION - Anticoagulation Treatment Influence on Post-operative Patients". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00187304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*